Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
102.92
+0.07 (0.07%)
At close: Sep 4, 2026, 4:00 PM EDT
102.53
-0.39 (-0.38%)
After-hours: Sep 4, 2026, 7:46 PM EDT

Haemonetics Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Net Income
96.2997.31167.68117.56115.443.38
Depreciation & Amortization
103.97105.62108.8988.6284.8186.55
Other Amortization
6.16.16.78.68.511.8
Loss (Gain) From Sale of Assets
-0.71-0.71-15.7-1.01-0.94-9.6
Asset Writedown & Restructuring Costs
86.5586.552.3910.420.6110.75
Stock-Based Compensation
33.8333.8329.6428.3325.5824.36
Other Operating Activities
-9.69-11.81-15.913.9413.620.21
Change in Accounts Receivable
-18.14-14.886.96-24.19-24.42-34.97
Change in Inventory
43.0647.36-64.7-60.0630.7524.31
Change in Accounts Payable
18.71-16.57-19.2144.5839.827.64
Change in Income Taxes
-1.78-4.530.23-0.981.692.87
Change in Other Net Operating Assets
-30.03-35.03-25.23-34.05-22.33-15.02
Operating Cash Flow
328.15293.22181.73181.75273.06172.26
Operating Cash Flow Growth
44.85%61.35%-0.01%-33.44%58.51%58.32%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Capital Expenditures
-36.93-32.78-39.28-38.13-191.33-96.51
Sale of Property, Plant & Equipment
1.321.3823.251.811.612.02
Cash Acquisitions
-60.18-60.18-150.91-243.85-2.85-2.5
Divestitures
--43.291.50.8510.64
Investment in Securities
-26.99-36.07-17.14-15.55-33.21-
Other Investing Activities
-46-51.89-21.11-28.1781.14-
Investing Cash Flow
-168.78-179.55-161.9-322.39-143.79-86.35

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Long-Term Debt Issued
-300950110330-
Total Debt Issued
300300950110330-
Long-Term Debt Repaid
--306.25-502.69-72.25-339.63-17.5
Total Debt Repaid
-356.25-306.25-502.69-72.25-339.63-17.5
Net Debt Issued (Repaid)
-56.25-6.25447.3137.75-9.63-17.5
Issuance of Common Stock
7.57.898.337.217.026.55
Repurchase of Common Stock
-178.72-180-235.24-5.89-75-
Other Financing Activities
-0.08-0.1-111.58-0.92-22.76-4.8
Financing Cash Flow
-227.55-178.46108.8238.16-100.36-15.75

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Foreign Exchange Rate Adjustments
-1.343.46-0.69-3.19-3.94-2.98
Net Cash Flow
-69.51-61.32127.96-105.6724.9767.19

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Free Cash Flow
291.22260.44142.45143.6381.7375.75
Free Cash Flow Growth
53.95%82.83%-0.82%75.73%7.89%5.56%
Free Cash Flow Margin
21.54%19.52%10.47%10.97%6.99%7.63%
Free Cash Flow Per Share
6.245.502.812.791.591.48
Levered Free Cash Flow
312.84298.09183.89148.5350.0988.9
Unlevered Free Cash Flow
329.97310.16206.33160.7258.2189.12

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Cash Interest Paid
17.4717.4716.5320.913.596.19
Cash Income Tax Paid
60.6760.6749.2952.7117.9724.3
Change in Working Capital
11.83-23.65-101.96-74.725.5-15.18
SEC Filings: 10-K · 10-Q